Glioblastoma: Update on Treatment and Research (Part 2: Q&A)
Watch this additional video for a second recording with Dr. Easaw where he answers the questions, we did not have time for during the webinar. Thanks to everyone for your contributions – we had a total of 52 questions come through during the webinar – the most we’ve ever received! Presented by Dr. Jay Easaw Dr. Jay Easaw is a Professor in the Division of Medical Oncology at the Cross Cancer Institute in Edmonton, Alberta. He is board certified in internal medicine and medical oncology. He is actively involved in both patient care and clinical research. Dr. Easaw’s research interests include metabolomics, database design, clinical informatics, and the introduction of technology into clinic. He is a recent recipient of awards in both teaching and research excellence. - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Connect with Brain Tumour Foundation of Canada: Facebook: / braintumourfdn Twitter: / braintumourfdn Instagram: / braintumourfdn Call Toll Free 1-800-265-5106 or locally 519-642-7755 - call with any questions and connect today! Brain Tumour Foundation of Canada 205 Horton St E, Suite 203, London, ON N6B 1K7 http://www.BrainTumour.ca Charitable Registration #BN118816339RR0001 Copyright and Terms of Use Statement - Videos Copyright of all videos created by Brain Tumour Foundation of Canada on this website, including the underlying HTML, text, illustrations, designs, icons, audio clips, video clips, documents, products, software and all other content is either owned by the Brain Tumour Foundation of Canada, or Brain Tumour Foundation of Canada has obtained a license to use the materials. The videos on the site are protected by the Copyright Act. None of the videos may be copied, reproduced, distributed, republished, downloaded, or transmitted in any form or by any means, without the prior written consent of Brain Tumour Foundation of Canada, or the original creator, where applicable. All information within the videos has been posted to provide Canadians affected by a brain tumour with support, education, information and an understanding of research programs or to thank donors and supporters for their contributions. The information has been posted with the intent that it be readily available for personal and public non-commercial (educational) use. The allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research.

Glioblastoma: Update on Treatment and Research

Glioblastoma: Exploring the biological underpinnings of why this cancer remains so hard to treat

Program Information Session ~ Autism and Behavioral Science

The power of sound: Focused ultrasound in brain cancer | Brain Tumour Webinar Series

Antineoplastic Agents | Clinical Medicine

She Was Trying to Cut It With Scissors and The Grass Was Taller Than My Mowers

Battling DIPG: An Incurable Childhood Brain Tumor

Community Responses to Threats to Latino Health and Well-Being: Local Asset-Based Strategies

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD

Health Update: A New Perspective On Life

Is the Chemotherapy Working (Brain Tumour Webinar Series)

Strategies for unimaginable adversity | Brain Tumour Webinar Series

Neurocognitive outcomes in advanced metastatic cancer patients - Dr. David Schultz

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

Primary brain tumour statistics in Canada: Incidence, prevalence and survival rates | Webinar Series

Shade Tree Used Car Lot Strikes AGAIN! (Customer JUST BOUGHT this CAR) 2007 Kia Optima 2.4

George’s Journey Facing Brain Cancer | Memorial Sloan Kettering Cancer Center

Creating a neuro-oncology program through the empowerment of patients and providers | Webinar Series

Advancing Substance Use Disorder Treatment Through Measurement-Based Care

